Synthorx’s Shawver Joins Silverback Therapeutics as New Top Exec | Sarah de Crescenzo | 04/22/20 | Seattle |
Xilio Unveils New Name, $100M to Bring Targeted Cancer Drugs to Clinic | Frank Vinluan | 03/02/20 | Boston |
Bio Roundup: Sarepta’s Approval, Merck M&A, Drug Price Bill & More | Frank Vinluan | 12/13/19 | National |
Eying Cancer Combos, Sanofi to Splash Out $2.5B on San Diego’s Synthorx | Sarah de Crescenzo | 12/09/19 | San Diego |
San Diego Tallies 7 IPOs in Best Year for Market Debuts Since 2014 | Sarah de Crescenzo | 12/15/18 | San Diego |
Synthorx Gets $131M in Upsized IPO for Synthetic Biology Drugs | Sarah de Crescenzo | 12/07/18 | San Diego |
Bio Roundup: ASH Wrap, CRISPR Baby Fallout, Moderna’s Record IPO | Ben Fidler | 12/07/18 | National |
Bio Roundup: Moderna’s IPO, Arena’s Comeback, E-Cig Survey & More | Frank Vinluan | 11/16/18 | National |
Synthorx Files for IPO to Advance Enhanced Cytokine Drugs | Sarah de Crescenzo | 11/14/18 | San Diego |
With $1.6B Armo Buy, Eli Lilly Is the Latest to Bet Big on Cytokines | Frank Vinluan | 05/10/18 | Indiana |
Synthorx Raises $63M to Advance Suite of Enhanced Cytokine Drugs | Bruce V. Bigelow | 04/30/18 | San Diego |
Biotech Roundup: Scangos’s Exit, Zafgen’s Shakeup, Jounce, Relypsa & More | Ben Fidler | 07/22/16 | National |
Synthorx Raises $10M to Expand Use of Synthetic DNA in Biologics | Bruce V. Bigelow | 07/20/16 | San Diego |
Synthorx Obtains $10,000,000 Series B Financing | VentureDeal | 07/20/16 | San Diego |
12 San Diego Life Sciences Startups to Watch in 2016 | Bruce V. Bigelow | 02/09/16 | San Diego |
West Coast Biotech Roundup: Adaptive, Synthorx, USC v. UCSD, 23andMe | Alex Lash | 08/20/15 | San Diego |
Synthorx Makes Proteins Using Expanded Alphabet of Synthetic DNA | Bruce V. Bigelow | 08/20/15 | San Diego |
West Coast Biotech Roundup: Gilead/AbbVie, Juno, Auspex, Bina & More | Alex Lash | 12/23/14 | San Francisco |
West Coast Biotech Roundup: Alder IPO, Exelixis, Corcept, and More | Bruce V. Bigelow | 05/09/14 | San Diego |